SCHEMBL30838283

SCHEMBL30838283

Cn1cnnc1CC1(c2cccc(NC(=O)c3cc(CN4CCCCC4)cn(C4CC4)c3=O)c2)COC1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 20/20 0.55
▸ CBLC Q9ULV8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30838316 0.90 CBLB (0.55) CBLBCBLC
SCHEMBL30838190 0.90 CBLB (0.55) CBLBCBLC
SCHEMBL30838298 0.86 CBLB (0.56) CBLB
SCHEMBL30838326 0.83 CBLB (0.55) CBLBCBLC
SCHEMBL30838251 0.82 CBLB (0.48) CBLBCBLC
SCHEMBL25349273 0.78 CBLB (0.54) CBLBCBLC
SCHEMBL25349446 0.78 CBLB (0.57) CBLBCBLC
SCHEMBL21200940 0.78 CBLB (0.77) CBLB
SCHEMBL29867318 0.78 CBLB (0.77) CBLB
SCHEMBL25348766 0.78 CBLB (0.55) CBLBCBLC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4573085-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2025-06-25 — — EP claimed
WO-2024038378-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-02-22 — — WO claimed
Send feedback